Dr. Panchaxari M. Dandagi

Dr. Panchaxari M. Dandagi M. PHARM Ph.D PROFESSOR & HEAD DEPARTMENT OF PHARMACEUTICS. KLE University’s COLLEGE OF PHARMACY NEHRUNAGAR, BELGAUM- 590 010. KARNATAKA, INDIA.

MISSION Achieve academic excellence by educating and training the young budding pharmacist, who has a major role to play in the healthcare system.

OBJECTIVE Train the UG & PG students to ensure high competence in the field of pharmacy and prepare him/her for carrier in industry, research and academics. Foster professional honesty and integrity, develop oral and written communication skills, leadership skills and to have high moral and ethical standards.

PARENTS Late Shri. Mallappa N. Dandagi and Smt. Mahadevi M. Dandagi

DATE OF BIRTH : 15TH May 1965.

RESIDENCIAL ADDRESS : A 13/2, Staff Quarters, J.N.M.C. Campus. Nehru Nagar BELGAUM - 590 010.

CONTACT @ : [email protected] [email protected]

PHONE/ FAX/ MOBILE Nos : +91-831-2471399 [ ] +91-831-2472387 [] +91-831-2471834 [Resi] +91-9448527154 [Mobile]

PRESENT BASIC PAY : 20,000/ -

______C.V of P .M. Dandagi 1 FIELD OF INTEREST Exploring and Developing of novel drug delivery systems including nanopaticles, microspheres, microcapsules and colon delivery systems. ACADEMIC QUALIFICATION College/University Degree University Year Result/ Field of Class Specialization KLES College of B. Pharm Karnataka May 70.80% Pharmacy Pharmacy, University 1991 Belgaum Dharwad. Govt. College of M. Bangalore May 70.60% Pharmaceutic Pharmacy, Pharm University 1993 s Bangalore KLES College of Ph.D RGUHS Feb Awarde Herbal Pharmacy, Bangalore 2009 d Formulation Belgaum

ACHIEVEMENTS 1. Secured Third Rank in B.Pharm Examination from Karnataka University, Dharwad. 2. Qualified GATE-91 Examination with 99.07 Percentile.

PROFESSIONAL EXPERIENCE : (Starting From Present Position)

College/University Designation Period

KLES College of Pharmacy, Professor & Head 01/10/2010 To Belgaum. Till date KLES College of Pharmacy, Professor 01/04/2009 Belgaum. To 30/09/2010 KLES College of Pharmacy, Associate Professor 01-09-2005 To Belgaum. 31/03/2009 KLES College of Pharmacy, Assistant Professor 01-11-1999 To Belgaum. 31-08-2005 KLES College of Pharmacy, Lecturer 01-09-1996 To Belgaum. 31-10-1999 KLES College of Pharmacy, Lecturer 17-10-1994 To Hubli. 31-08-1996 Sanjay Patil College of Principal 01-06-1993 To Pharmacy, Sankeshwar. [D.Pharm College] 30-09-1994 Total Teaching Experience: 19 Years Total Research Experience: 13 Years RESEARCH PUBLICATIONS AND PRESENTATIONS

______C.V of Dr. P .M. Dandagi - 2 Papers Published in Referred Papers Presented in Journals # Conferences @ 38 32 06 43 {National] [International] # List Enclosed Annexure- I @ List Enclosed Annexure- II FELLOWSHIP OF ACADEMIC BODIES AND PROFESSIONAL SOCIETIES Received Junior Research Fellowship [JRF] during the period between 1991 and 1993 At Government College of Pharmacy, Bangalore.

EXAMINERSHIP 1. Recognized by Rajiv Gandhi University of Health Sciences, Bangalore for both Under Graduate and Post Graduate level since 1996. 2. Recognized by Shivaji University, Kolhapur.

3. Recognized by Bangalore University, Bangalore for Under Graduate level. 4. Recognized by Manipal University, Manipal

5. Recognized by Karnataka University, Dharwad for Under Graduate level. 6. Recognized by Goa University, Panjim for Under Graduate level.

MEMBERSHIP OF SCIENTIFIC AND PROFESSIONAL SOCIETIES  Life Member Indian Pharmaceutical Association [KTK/BEL/LM/023]

 Life Member Association of Pharm Teachers of India [KA-LM/120]

 Served as Treasurer, Scientific Society, KLES’s College of

Pharmacy, Belgaum.

 Registered Pharmacist at Karnataka State Pharmacy Council,

Bangalore. Reg. No: 15591. Dated: 05/03/1993.

 Served as Pharmacy Inspector by Karnataka State Pharmacy Council

 Reviewer for Indian Journal of Pharmaceutical Education and

Research [IJPER] ______C.V of Dr. P .M. Dandagi - 3  Member, LIC for Rajiv Gandhi University of Health Sciences, Bangalore.

 Ex-Member, Board of Studies (BOS) for PG course ((2006-09) for Rajiv Gandhi University of Health Sciences, Bangalore.

LIST OF CONFERENCES AND SHORT TERM COURSES ETC ORGANISED OR PARTICIPATED  Organized as a Programme Co-ordinator of two week Quality Improvement Programme in Feb – March 2001  Attended Indian Pharmaceutical Congress (IPC) [09] at Goa, Bangalore, Vishakapatnam, Mumbai, Pune, Chennai, Kolkota, BHU Varanasi(2007), Ahmedabad(2009) and Manipal(2010)  Participated in Controlled Release Societies International Conventions [03] at At hotel Cidade-de-Goa, Panjim Goa on 19 & 20th Feb 1999, PERD Center, Ahmedabad on 4, 5 & 6th Feb 2000. At Sci.Tech Center, Jogeshwari, Mumbai on 22 & 23rd 2002.  Delivered a Guest Lecture at RASASADHANA-05 organized by Shri B.M. Kankanawadi Ayurved Mahavidyalaya, Belgaum on 20th January 2005.  Attended APTI National Conventions at Bangalore (2), Hubli, Nagpur and Vishakapatnam  Actively Participated in 4th I.P.A National Convention on Pharmaceutical Education, at KLES’s College of Pharmacy Belgaum on 25 & 26th Sept 1998.  Served as Treasurer L.O.C of 2ndGlobal Congress on Cosmetic Technologies at KLES’s College of Pharmacy, Belgaum.  Attended as Delegate in One-Day workshop on Teaching Methodology held at KLES’s College of Pharmacy Belgaum.  Served as Treasurer, L.O.C for 2nd International Symposium on Drug Discovery and Process Research held at KLES’s College of Pharmacy, Belgaum. On 10th –12th February 2006.  Served as Co-chairman of poster session at 60th IPC held at BHU Varanasi (UP) 2007.  Attended and Participated in 3rd Congress on Cosmetic Technologies at KLES’s College of Pharmacy, Belgaum.  Served as Convener for two weeks Quality Improvement Program on Quality Assurance at KLES College of pharmacy, Belgaum.  Served as Chairman of scientific session at 61st IPC at Ahmedabad 2009.

______C.V of Dr. P .M. Dandagi - 4  Chaired oral session and Presented research paper at “International conference on Pharmaceutical, Nutraceutical & Cosmaceutical Technology: Formulations and Applications” held at Kuala Lumpur, Malaysia on 25, 26 & 27th of May 2010.  Chaired scientific session at 62nd IPC Manipal 2010 CONSULTANCY AND SPONSORED RESEARCH ACTIVITIES Year Organization Project Title Amount Receive d 1992-93 K.S.C.S.T. Formulation and Evaluation of 5000/- Bangalore Controlled Release Beads of Flurbiprofen Using Chitosan. 2003-04 R.G.U.H.S Dexamethasone Matrix Tablets 10,000/- Bangalore For Colon Specific Delivery For Inflammatory Bowel Disease. RESEARCH ACTIVITY Research guide for Post-graduate Students, approved by RGUHS, Bangalore, since 1999. Approval letter dated 19/05/99 Ref No-ACA/PGT- M.Ph/KLE/08/99-00/5583. Till date guided 45 and co-guided 03 Post Graduate students [Completed] At Present 05 students research work is in progress *. * List enclosed Annexure- III ANNEXURE -I RESEARCH PUBLICATIONS

1. “ Formulation of a Transdermal Drug Delivery System of Ketotifen Fumarate” Indian Journal of Pharmaceutical Sciences; 2003, 65 (3), 239-243. 2. “ Development and Evaluation of Ketorolac Tromethamine Ocular Films” Indian Drugs, 2003, 40 (6), 369-371. 3. “ Development and Evaluation of Ocular Films of Cromolyn Sodium” Indian Journal of Pharmaceutical Sciences; 2004, 66 (3), 309-312. 4. “Microencapsulation of Verapamil HCl By Ionotropic Gelation Technique” Indian Journal of Pharmaceutical Sciences; 2004, 66 (5), 631-635. 5. “Taste Masked Oflaxacin Mouth Disintegrating Tablets” Indian Drugs 42 (1) 2005, 52-55. 6. “ Development and Evaluation of Theophylline and Salbutamol Sulphate Sustained Release Matrix Tablets”, Indian Journal of Pharmaceutical Sciences, 2005(67 (05), 598-602. 7. “ Formulation and In vitro evaluation of Diltiazem Hydrochloride buccal films”. The Indian Pharmacist, IV (37) July 2005, 59-62.

______C.V of Dr. P .M. Dandagi - 5 8. “ Orodispersible Tablets: New-Frangled Drug Delivery System” Indian Journal of Pharmaceutical Education and Research, 39 (04), Oct- Dec2005, 177-181. 9. “ Biodegradable Microparticulate System of Captopril” International Journal of Pharmaceutics, 2006, 307 (01), 83-88. 10. “ Formulation and Evaluation of Ondansetron HCl Directly Compressed Mouth Disintegrating Tablets” Indian Drugs, 2006, 43(1), 35-37. 11. “ Formulations and Evaluation of Ornidazole Dental Implants for Periodontitis”, Indian Journal of Pharmaceutical Sciences, 2006 68(1), 68-71. 12. “ Non-Chewable Antacid Formulations: Effect of Different Disintegrating Agents on Their Acid Neutralization Properties” Indian Journal of Pharmaceutical Sciences, 2006, 68(2), 269-273. 13. “ Rapidly disintegrating Domperidone Tablets”, Indian Drugs, 2006, 43 (7) 594-597. 14. "Time and pH Dependent Colon Specific, Pulsatile Delivery of Theophylline for Nocturnal Asthma" International Journal of Pharmaceutics. 2007, 328(2),49-56. 15. “ Mucoadhesive microspheres of Propranolol HCl for nasal delivery” Indian Journal of Pharmaceutical Sciences, 2007, 69(3), 402-408. 16. “ Antiulcer activity of extracts of Cyperous rotundus rhizome in pylorus ligated rat model”. Advances in Pharmacology and Toxicology, 2007, 8(3), 117 – 122. 17. “ Antihypertensive activity of seeds of Mucuna prurunes in dexamethasone induced hypertension in rats” Advances in Pharmacology and Toxicology, 2007, 8(3), 59 – 62. 18. “ Antidiabetic activity of fruits Punica granatum and seeds of Mucuna prurunes in alloxan induced diabetic rats”. International journal of Pharmacology and Biological Sciences, 2007, 1(3), 29-32 19. "In vitro in vivo evaluation of Ranitidine HCl ethyl cellulose floating microparticles” Journal of Microencapsulation, 2008: 13(3): 1-8. 20. “ Antiulcer activity of extracts of Calotropis gigantean roots in pylorus ligated rat model”. International journal of Pharmacology and Biological Sciences, 2008, 2(1), 127 – 132. 21. “Development and Evaluation of Hepatoprotective Polyherbal Formulation Containing Some Indigenous Medicinal Plants” Indian Journal of Pharmaceutical Sciences, 2008, 70(2), 265-268. 22. “Antidiabetic activity of flower buds of Hibiscus rosa sinensis and leaves of Moringa olefera in alloxan induced diabetic rats” Advances in Pharmacology and Toxicology, 2008, 9(2), 99 – 103. 23. “Design and evaluation of bilayer floating gastro-retentive tablets for the controlled delivery of Clarithromycin” International journal of Pharmacology and Biological Sciences 2009, 3(1), 27-34. 24. “Floating bilayer tablet for drug delivery system containing Cefpodoxime proxetil for prolonged gastric residence” J. Chemical and Pharmaceutical Sciences Vol. 2 (1) Jan – Mar 2009, 38-44. ______C.V of Dr. P .M. Dandagi - 6 25. “ Sodium Alginate Polymeric Floating Beads for the Delivery of Cefpodoxime Proxetil” Journal of Applied Polymer Science 2009; 114(3), 1921-26. 26. “Polymeric ocular Nanosuspension for controlled release of acyclovir: in vitro release and ocular distribution”. Iranian Journal of Pharmaceutical Research 2009, 8 (2): 79-86 27. “ pH- Sensitive Mebaverine microspheres for colon delivery” Indian Journal of Pharmaceutical Sciences, 2009, 71(4), 464-68 28. “ Controlled Release Polymeric Ocular Delivery of Acyclovir” Pharmaceutical Development and Technology, 2010, 15(4), 369-378. 29. Preparation and evaluation of Sparfloxacin Dental Implants for treatment of periodontal diseases. International Journal of Pharm Sciences, 2010 2(2), 606-611 30. Development and characterization of a particulate drug delivery system for Etoposide, Indian Journal of Novel Drug Delivery 3(1), Jan-Mar, 2011, 43-51 31. Design and Evaluation of Aceclofenac Loaded Microsponge for Topical Delivery. Journal of Pharmaceutical Research & Clinical Practice, Apr-June 2011; 1(2):90-101 32. Enhancement Of Solubility And Dissolution Property Of Griseofulvin By Nanocrystallization, Int. J. Drug Dev. & Res., April-June 2011, 3 (2): 128-139 33. Oral osmotic drug delivery system- An update, International journal of research in pharmaceutical sciences. 2011, 2(2), 225-236. 34. Formulation and Evaluation of Floating Microspheres of Captopril for Prolonged Gastric Residence Time, Indian Journal of Novel Drug Delivery 3(1), Jan-Mar, 2011, 17-23. 35. Development and Characterization of a Particulate Drug Delivery System for Etoposide, Inventi Impact: NDDS Vol. 2011, Issue 1, 36-41 36. Design and Characterization of Clotrimazole Nanoparticles: An Approach to Controlled Drug Delivery, Inventi Impact: NDDS Vol. 2011, Issue 1, 22-26. 37. Formulation And Evaluation Of Metoclopramide Rapidly Disintegrating Tablets, Journal of Drug Delivery & Therapeutics; 2011, 1(2): 10-14 38. Formulation And Effect Of Viscosity And Concentration Of Methocel On Release Characteristics Of Trimetazidine Matrix Tablets, International Journal of Pharmacy and Pharmaceutical Sciences Vol 4, Issue 1, 2012

______C.V of Dr. P .M. Dandagi - 7 ANNEXURE -II REASERCH PRESENTATIONS

1. “Application of Chitosan as Carrier for Oral Controlled Release Dosage Form” 47Th Indian Pharmaceutical Congress, Vishakapatnam [AP] on 27- 29th Dec 1995. 2. “ Transdermal Films of Salbutamol Sulphate: Effect of Permeation Enhancers” 52nd Indian Pharmaceutical Congress Hyderabad [AP] on 18- 20th Dec 2000. 3. “ Development and Characterization of Transdermal Films of Ketotifen Fumarate using Ethyl Cellulose and HPMC” 4th International Symposium on Controlled Release Society, SciTech Centre, Mumbai. 22 & 23rd Feb 2003. 4. “Effect of Enhancers on Drug Release Kinetics of Transdermal Films of Ketotifen Fumarate” 4th International Symposium on Controlled Release Society, SciTech Centre, Mumbai. 22 & 23rd Feb 2003.

______C.V of Dr. P .M. Dandagi - 8 5. “Development and Evaluation of Ocular Films of Cromolyn Sodium” 54Th Indian Pharmaceutical Congress, Pune on 13, 14 &15 Dec 2002. 6. “ Development of Mucoadhesive Tablets for Oral Controlled Release of Astemizole” 8Th APTI National Convention Hubli. 17 & 18th Oct 2003. 7. “Transdermal Films of Terbutaline Sulphate; Effect of Plastisizer on Drug Release Kinetics” 8Th APTI National Convention, Hubli. 17 & 18th Oct 2003. 8. “ Development of Wound Healing Herbal Formulation from Petroleum Ether Extract of Coctus Speciosus” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13,14 &15 Feb 2004. 9. “ Development of Wound Healing Herbal Formulation from Benzene Extract of Curcuma Domestica” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13, 14 &15 Feb 2004. 10.“ Development of Wound Healing Herbal Formulation from Benzene Extract of Terminalia Chebula” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13, 14 &15 Feb 2004. 11.“ Design, Formulation and Comparative Evaluation of Thiophylline and Salbutamol Sulphate Matrix Tablets” International Convention of APTI 2004, at Vishakapatnam, AP, 2nd and 3rd October 2004. 12.“Dexamethasone Matrix Tablets For Colon Specific Delivery Using Guar Gum” at 56th IPC Kolkata, 4th Dec 2004. 13.“ Formulations and Evaluation of Ornidazole Dental Implants for Periodontitis” at 56th IPC Kolkata, 4th Dec 2004. 14.“ Flurbiprofen Microbeads for Controlled Release” International Convention of APTI 2004, at Vishakapatnam, AP, 2nd and 3rd October 2004. 15.Presented a Paper in National Seminar and Workshop on Rasashastra- 2005 organized by KLES Shri B. M. Kankanwadi Ayurvedic Mahavidyalaya, Belgaum on 19th and 20th January 05. 16.“Development of Sparfloxacin dental implants for treatment of Periodontal Diseases. 57th IPC held at Hyderabad on 1 to 3 Dec 2005. 17.“Development of Moxifloxacin dental implants for treatment of Periodontal Diseases” 10th APTI National Convention at Nagpur on 17th and 18th Oct 2005. 18.“Development and Evaluation of herbal formulation of Commiphora mukul plant extract” at 57th Indian Pharmaceutical Congress held at Hyderabad on 1 to 3 Dec 2005. 19.“ Colon Specific Delivary of a Cox2 Preferential inhibiter” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 20.“Formulation and Evaluation of pH Dependent Eudragit Microcapsules for colon targetting” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.

______C.V of Dr. P .M. Dandagi - 9 21.“ Influence of ɑ-Cyclodextrine on Solubility of Acyclovir” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 22.“ Formulation and Evaluation of Bromhexine CR Tablets” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 23.“ Development and Evaluation of Hepatoprotective Polyherbal Formulation” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 24.“ Formulation and Charecterisation of Mucoadhesive Microspheres of Propranolol HCl for nasal Delivery” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 25.“ Effect of Tween 20 and Tween 40 on 5-Flurouracil niosomes” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 26.“Design and Charecterisation of Orodispersible Valdecoxib Tablets” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 27.“Design and charecterisation of floating microspheres of an antiulcer drug: an approach to oral controlled drug delivary via gastric retention” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 28.“Formulation and Evaluation of Polyherbal Antidiabetic Preparation” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006. 29. “ Antiulcer Activity of extracts of Cyperous rotundas a national level Symposium SYNAPSE-2007 held at College of Engineering and Technology, Belgaum, on 27th and 28th March 2007. 30. “Design and evaluation of Acyclovir ocular inserts for once a day therapy- A novel approach” 59th IPC, BHU, Varanasi on 20th-23rd Dec 2007. 31.“Design and Charecterization of pH-sensitive microspheres of Mebaverine for Colon Delivery” 60th IPC, New Delhi, 12-14th Dec 2008. 32.“ Clotrimazole engineered Poly-lactide-co-glycolide nanoparticles” Young Researchers Conference-09, Institute of Chemical Technology, Mumbai. 27-28th January 2009. 33.“ Design & characterization of colon targeted nimesulide double coated tablets for the prophylaxis of colon cancer” 61st IPC, Ahmedabad, 11th-13th Dec 2009. 34.“ Design & Characterization of pH sensitive microspheres of mebaverine for colon delivery” 61st IPC, Ahmedabad, 11th-13th Dec 2009. 35. “ Nanocrystallization As An Approach To Enhance Dissolution Of Griseofulvin” Pharmatech 2010 at Kuala Lumpur, 25- 27th May 2010

______C.V of Dr. P .M. Dandagi - 10 36. “ Development and Characterization Of A Particulate Drug Delivery System For Etoposide” Pharmatech 2010 at Kuala Lumpur, 25- 27th May 2010. 37.“ Formulation & Release study of Trimetazidine Matrix Tablets using Methocel” Indian Pharmaceutical Congress at Manipal December 2010. (mihir) 38. “ Enhancement of solubility & dissolution property of Griseofulvin by Nanocrystallization” Indian Pharmaceutical Congress at Manipal December 2010.(sumit) 39.Formulation And In Vitro Evaluation Of Mucoadhesive Microcapsules Of Aceclofenac For Oral Controlled Release, 63rd IPC Bangalore 16- 18 Dec 2011 (Patel Chirag P.)* 40.Design and Optimization of Delayed Release Pellets using Response Surface Methodology, 63rd IPC Bangalore 16- 18 Dec 2011 (Girish. B), 41.Formulation And Evalution Of Non-Steroidal Anti-Inflammatory Drug Loaded Microsponge For Topical Delivery, 63rd IPC Bangalore 16- 18 Dec 2011 (Pandey C.K.)*, 42. Design And Evaluation Of Aceclofenac Loaded Microsponge For Topical Delivery, 63rd IPC Bangalore 16- 18 Dec 2011 (Nagratna.G.Dhople), 43. Formulation Development And Evaluation Of Colon Targeted Beads Of Mesalamine, 63rd IPC Bangalore 16- 18 Dec 2011 (Suryasri Lavanya Adavi),

ANNEXURE -III TITLES OF PG. DISSERTATION WORK

______C.V of Dr. P .M. Dandagi - 11 1. Development and characterization of a buccoadhesive dosage form of propranolol hydrochloride. [Sajan Jose, 1998]* 2. Formulation and in vitro release study of oral extended release Verapamil Hydrochloride tablet from various cation exchange resins. [Anurag varma, 1998]* 3. Development of Mucoadhesive tablets for oral controlled release of Astemizole. [Abhay Pawar, 1998]* 4. Development and evaluation of Transdermal films of Nifedipine. [Sandeep Singhvi, 1999] 5. Studies on sustained release Diltiazem matrix tablets and effect of binders on drug release. [Venkatesh.J.S, 1999] 6. Development and evaluation of ocular films of Cromolyn Sodium. [Rahul Rathod, 2000] 7. Development and evaluation of Transdermal films of Salbutamol Sulphate. [Yuvraj Singh, 2000] 8. Transdermal films of Terbutaline Sulphate and effect of Plastisizer type and concentration on release kinetics. [Abhay Joshi, 2001] 9. Preparation and evaluation of diclofenac sodium ocular inserts using ethyl cellulose and cellulose acetate. [Swapnil Phade, 2001] 10.An approach to the formulation of a TDDS of Ketotifen Fumarate. [Jagadeesh. T, 2002] 11.Development and evaluation of Ketorolac Tromethamine ocuserts. [Balasaheb. Wagh, 2002] 12.Formulation and in vitro charecterization of Diltiazem HCl films for Buccal Patches. [Thomas. P.T, 2002] 13.Microencapsulation of Verapamil HCl by ionotropic gelation technique. [Balamuralidhara. V, 2003] 14.Design and evaluation of polymeric ocular drug delivery system for controlled release of Flurbiprofen sodium. [Sarvesh Malviya, 2003] 15.Taste masked ofloxacin mouth dissolve tablets. [Sreenivas. S.A, 2004] 16.Dexamethasone matrix tablets for colon specific delivery for inflammatory bowel diseases. [Ravindra Singh, 2004] 17.Design, formulation and comparative evaluation of theophylline and Salbutamol Sulphate matrix tablet for SR combined dosage form. [Ruchi Sharma, 2004] 18.Formulation and evaluation of Domperidone rapidly disintegrating tablets. [Prabhu. K.H, 2005] 19.Biodegradable micro particulate system of Captopril. [Manish Kumar. G, 2005] 20.Preparation and evaluation of Sparfloxacin dental implants for treatment of periodontal diseases. [Sujata. D, 2005] 21.Development and evaluation of hepatoprotective polyherbal formulation. [Rajakumar Dhumansure, 2006] 22.Design and characterization of colon targeted Nimesulide double-coated tablets for the prophylaxis of colon cancer. [Shaik Mohd. Asif, 2006]

______C.V of Dr. P .M. Dandagi - 12 23.Formulation and characterization of Mucoadhesive microspheres of propranolol for nasal delivery. [Sudhir Iliger, 2006] 24.Design and evaluation of acyclovir ocular inserts for once a day therapy- A novel approach. [Praful Deshpande, 2006] 25. Formulation and Characterization of Famotidine Floating Microspheres. [Senthilkumar. R 2007] 26.Formulation and Characterization of Acyclovir loaded Nanosuspensions for Ophthalmic Delivery. [Shashidhar Kerur 2007] 27.Design and Characterization of Clotrimazole Nanoparticles- An approach to controlled Drug Delivery. [Sandeepkumar April 2008] 28.Design and Characterization of pH sensitive microspheres of Mebaverine for colon delivery. [Bharamappa Konnur April 2008] 29.Formulation and evaluation of Metaclopramide rapidly disintegrating tablet [Shashank J. Mohite Feb 2009] 30.Formulation and evaluation of Pilocarpine loaded Chitosan nanoparticles. [Bheemanna Munnur Feb 2009] 31.Formulation and Evaluation of Extended release Tablets of Ranolizine by solvent free hot melt coagulation Technique. [Ms Jignaben Umeshbhai Patel April 2010] 32. Formulation and in vitro evaluation of taste masked orodispersible tablets of levocetirizine. [Mrs Sumati Suresh Puri April 2010] 33.Enhancement of solubility and dissolution properties of Griseofulvin by nanocrystallization technique. [Mr. Shaktish Telsang April 2010] 34.Formulation and In Vitro evaluation of Aceclofenac Microcapsules for oral controlled release. [Mr. Divyanshu S. Raval May 2010] 35.Design & Evaluation of Acelofenac loaded microsponge for topical delivery [Mr. Mihir Upadhyay]. 36.Development & evaluation of solid lipid nanoparticles containing anti retroviral- stavudine [Mr. Punit D Patel]. 37.Formulation development & evaluation of colon targeted beads of mesalamine[Mr. Sumit Kaushik]. 38.Fabrication & in vitro evaluation of porous osmotic pump based controlled drug delivery of metoprolol succinate [Mr. Koradia Navik]. 39.Design & characterization of Flurbiprofen loaded polymeric nanosuspension for ophthalmic application [Mr. Mayank M. Sanghvi]. 40.Formulation and evaluation of ocular bioadhesive microspheres of moxifloxacin hydrochloride [Mr. Amit Belekar] 41.Design and characterization of diclofenac diethylamine in adhesive type transdermal therapeutic system [Ms. Saujanya P.] 42.Proniosomes as a carrier for transdermal delivery of clotrimazole [Mr. Pankaj Shukla] 43.Thermoreversible mucoadhesive gel for the nasal delivery of metaproterenol sulfate for the management of bronchospasm [Ms. Rini Thomas] 44.pH dependent, time delayed, microbially triggered in-layered tablets of 5- flurouracil for colon targeting [Mr. Anilkumar AVS] ______C.V of Dr. P .M. Dandagi - 13 * As Co-guide.

______C.V of Dr. P .M. Dandagi - 14